UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 31, 2016

 

 

XYLEM INC.

(Exact name of registrant as specified in its charter)

 

 

 

Indiana   001-35229   45-2080495

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1 International Drive

Rye Brook, New York

  10573
(Address of principal executive offices)   (Zip Code)

(914) 323-5700

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01. Entry into a Material Definitive Agreement.

As previously announced, on August 15, 2016, Xylem Inc. (the “Company”), Xylem Luxembourg S.à r.L., a Luxembourg société à responsabilité limitée and wholly-owned indirect subsidiary of the Company (“Xylem Lux” and, together with the Company, “Xylem”), Sensus Worldwide Limited, an exempted company incorporated under the laws of Bermuda (“Sensus Worldwide”), Sensus Industries Limited, an exempted company incorporated under the laws of Bermuda and wholly-owned subsidiary of Sensus Worldwide (“Sensus Industries”), and Sensus USA Inc., a Delaware corporation and wholly-owned subsidiary of Sensus Worldwide (“Sensus USA” and, together with Sensus Worldwide and Sensus Industries, “Sensus”), entered into a Share Purchase Agreement (the “Share Purchase Agreement”) regarding the acquisition of all of the direct and indirect subsidiaries of Sensus Worldwide, other than Sensus Industries.

On October 31, 2016, Xylem and Sensus entered into the First Amendment to the Share Purchase Agreement (the “Amendment” and the Share Purchase Agreement, as so amended, the “Purchase Agreement”), pursuant to which the parties agreed that the Company, rather than Xylem Lux, would be the indirect acquirer of the issued and outstanding equity of Sensus Metering Systems do Brasil Ltda, a subsidiary of Sensus USA, and to update the purchase price allocation between the Sensus entities.

Other than as expressly modified pursuant the Amendment, the Share Purchase Agreement, which was filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on August 15, 2016 and is incorporated herein by reference, remains in full force and effect as originally executed on August 15, 2016.

The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of (1) the Share Purchase Agreement, and (2) the Amendment, a copy of which is filed herewith as Exhibit 2.2 and incorporated herein by reference.

The Purchase Agreement has been included to provide investors and security holders with information regarding its terms. It is not intended to provide any other factual information about the Company, Xylem Lux, Sensus Worldwide, Sensus Industries, Sensus USA or any of their respective subsidiaries or affiliates. The representations, warranties and covenants contained in the Purchase Agreement (i) were made by the parties thereto only for purposes of that agreement and as of specific dates; (ii) were made solely for the benefit of the parties to the Purchase Agreement; (iii) may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures exchanged between the parties in connection with the execution of the Purchase Agreement (such disclosures include information that has been included in public disclosures, as well as additional non-public information); (iv) may have been made for the purposes of allocating contractual risk between the parties to the Purchase Agreement instead of establishing these matters as facts; and (v) may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company, Xylem Lux, Sensus Worldwide, Sensus Industries, Sensus USA or any of their respective subsidiaries or affiliates. Additionally, the representations, warranties, covenants, conditions and


other terms of the Purchase Agreement may be subject to subsequent waiver or modification. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the Purchase Agreement, which subsequent information may or may not be fully reflected in the Company’s public disclosures. The Purchase Agreement should not be read alone, but should instead be read in conjunction with the other information regarding the Company that is or will be contained in, or incorporated by reference into, the Forms 10-K, Forms 10-Q and other documents that are filed with the Securities and Exchange Commission.

 

Item 2.01. Completion of Acquisition or Disposition of Assets.

On October 31, 2016, the Company completed its previously announced acquisition of all of the direct and indirect subsidiaries of Sensus Worldwide (other than Sensus Industries) (the “Acquisition”) pursuant to the Purchase Agreement.

The aggregate consideration paid in the Acquisition was approximately $1,700,000,000 in cash, subject to certain adjustments as provided in the Purchase Agreement. The consideration was funded with a combination of cash on hand, proceeds from issuances under the Company’s existing commercial paper program, borrowings under a new euro-denominated term loan and the previously disclosed issuance of $500,000,000 aggregate principal amount of 3.250% Senior Notes due 2026 and $400,000,000 aggregate principal amount of 4.375% Senior Notes due 2046.

 

Item 2.02. Results of Operations and Financial Condition.

On November 1, 2016, the Company announced its financial results for the third quarter and nine months ended September 30, 2016. A copy of the press release which includes this announcement is furnished as Exhibit 99.1 to this report and is incorporated by reference herein.

This information, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 7.01. Regulation FD Disclosure.

On November 1, 2016, the Company issued a press release announcing the completion of the Acquisition. A copy of the press release which includes this announcement is furnished as Exhibit 99.1 to this report and is incorporated by reference herein. This information, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, and shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired

The Company intends to file the financial statements of Sensus required by Item 9.01(a) as part of an amendment to this Current Report on Form 8-K no later than 71 calendar days after the required filing date for this Current Report on Form 8-K.

(b) Pro Forma Financial Information

The Company intends to file the pro forma financial information required by Item 9.01(b) as an amendment to this Current Report on Form 8-K no later than 71 days after the required filing date for this Current Report on Form 8-K.


(d) Exhibits

 

Exhibit No.

  

Description

  2.1*    Share Purchase Agreement, dated as of August 15, 2016, by and among Xylem Inc., Xylem Luxembourg S.à r.l., Sensus Worldwide Limited, Sensus Industries Limited, and Sensus USA Inc. (incorporated by reference to Exhibit 2.1 to Xylem Inc.’s Current Report on Form 8-K filed on August 15, 2016).
  2.2    First Amendment to Share Purchase Agreement, dated as of October 31, 2016, by and among Xylem Inc., Xylem Luxembourg S.à r.l., Sensus Worldwide Limited, Sensus Industries Limited, and Sensus USA Inc.
99.1    Press Release issued by Xylem Inc. on November 1, 2016.

 

* Certain schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The descriptions of the omitted schedules and exhibits are contained within the Purchase Agreement. The Company hereby agrees to furnish a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     XYLEM INC.
Date: November 1, 2016                                                                                                    By:   

/s/ E. Mark Rajkowski

        Name: E. Mark Rajkowski
       

Title:  Senior Vice President and Chief

   Financial Officer

   (Authorized Officer of Registrant)


EXHIBIT INDEX

 

Exhibit No.

  

Description

  2.1*    Share Purchase Agreement, dated as of August 15, 2016, by and among Xylem Inc., Xylem Luxembourg S.à r.l., Sensus Worldwide Limited, Sensus Industries Limited, and Sensus USA Inc. (incorporated by reference to Exhibit 2.1 to Xylem Inc.’s Current Report on Form 8-K filed on August 15, 2016).
  2.2    First Amendment to the Share Purchase Agreement, dated as of October 31, 2016, by and among Xylem Inc., Xylem Luxembourg S.à r.l., Sensus Worldwide Limited, Sensus Industries Limited, and Sensus USA Inc.
99.1    Press Release issued by Xylem Inc. on November 1, 2016.

 

* Certain schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The descriptions of the omitted schedules and exhibits are contained within the Purchase Agreement. The Company hereby agrees to furnish a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request.

Exhibit 2.2

FIRST AMENDMENT TO THE SHARE PURCHASE AGREEMENT

This FIRST AMENDMENT TO THE SHARE PURCHASE AGREEMENT (this “Amendment”), dated as of October 31, 2016, amends that certain Share Purchase Agreement, dated as of August 15, 2016 (the “Agreement”), by and among Sensus Worldwide Limited, an exempted company incorporated under the laws of Bermuda (“Sensus Worldwide”), Sensus Industries Limited, an exempted company incorporated under the laws of Bermuda (“Sensus Industries”), Sensus USA Inc., a Delaware corporation (“Sensus USA” and, together with Sensus Worldwide and Sensus Industries, “Sellers”), Xylem Inc., an Indiana corporation (“US Buyer”), and Xylem Luxembourg S.à r.l., a Luxembourg, société à responsabilité limitée (“Lux Buyer” and, together with US Buyer, “Buyers”). Capitalized terms used and not defined herein shall have the respective meaning ascribed thereto in the Agreement.

WHEREAS, the Parties hereto have previously executed and delivered the Agreement;

WHEREAS, Section 10.1 of the Agreement provides that the Agreement may be amended, modified or supplemented but only in a writing signed by Buyers and Sellers; and

WHEREAS, Sellers and Buyers wish to amend the Agreement in the manner set forth herein.

NOW, THEREFORE, in connection with the Agreement, the transactions contemplated thereunder and the terms hereof, and in accordance with Section 10.1 of the Agreement, the Parties hereto agree as follows:

1. Amendments to Recitals.

 

  i. The third paragraph of the Recitals of the Agreement is hereby amended and restated in its entirety as follows:

“WHEREAS, Sensus USA, either directly or through one of its wholly-owned Subsidiaries, is the owner of all of the issued and outstanding equity interests (the “Sub Shares” and, together with the US Shares and the Luxco Shares, the “Shares”) of Sensus de Mexico, S. de RL de CV, a sociedad de responsabilidad limitada de capital variable organized under the laws of Mexico (“Sensus Mexico”), Sensus Chile S.A., a sociedad anónima organized under the laws of Chile (“Sensus Chile”), and Sensus Canada Inc., a Canadian corporation (“Sensus Canada” and, together with Sensus USA, Sensus Lux, Sensus Mexico and Sensus Chile, the “Companies” and each, a “Company”); and”

 

  ii. The fourth paragraph of the Recitals of the Agreement is hereby amended and restated in its entirety as follows:

“WHEREAS, (i) Sensus Industries wishes to sell, and Lux Buyer wishes to purchase, the Luxco Shares, and (ii) immediately thereafter, Sensus Worldwide wishes to sell, and US Buyer wishes to purchase, the US Shares, in each case, upon the terms and subject to the conditions set forth in this Agreement.”

 

1


2. Amendment to Section 1.1. Section 1.1 of the Agreement is hereby amended as follows:

 

  i. The definition of “Determination Time” is hereby amended and restated in its entirety as follows:

“‘Determination Time’ shall mean 11:59 p.m. (Eastern Time) on the Closing Date; provided that, notwithstanding the foregoing, all effects arising from the consummation of the transactions contemplated hereby will be disregarded for the purpose of making any determination, except with respect to the determination of Seller Transaction Expenses, as of the Determination Time.”

 

  ii. The definition of “Sensus Brazil” shall be deleted in its entirety.

3. Amendment to Section 2.5. Section 2.5 of the Agreement is hereby amended and restated in its entirety as follows:

Purchase Price Allocation. Sellers and Buyers agree that the amounts to be paid by Buyers to, or on behalf of, Sellers hereunder will be allocated in accordance with the fair market values of Sensus USA and the other Companies, the proportions of which are set forth on Exhibit A hereto (the “Allocation”). The Allocation shall be revised for any adjustments to the amounts to be paid by Buyers to, or on behalf of, Sellers hereunder pursuant to Section 2.4, with any adjustment that is specifically attributable to Sensus USA and its US subsidiaries allocated to Sensus USA, any adjustment that is specifically attributable to the other Companies and their subsidiaries allocated to such other Companies, and any adjustment that is not specifically attributable to Sensus USA and its US subsidiaries, on the one hand, or the other Companies and their subsidiaries, on the other hand, allocated pro rata between Sensus USA and the other Companies in accordance with the allocation on Exhibit A. Buyers shall send the revised Allocation to Sellers within thirty (30) calendar days after the determination of the Final Purchase Price pursuant to Section 2.4. Sellers and Buyers shall prepare and file their Tax Returns in a manner consistent with the Allocation. Except as required by Applicable Law, Sellers and Buyers agree that they will not take, or cause or permit to be taken, any position on any Tax Return that would be inconsistent with, prejudice or otherwise adversely affect the Allocation without the prior written consent of the other Party.”

4. Amendment to Section 5.13. The second sentence of Section 5.13 of the Agreement is hereby amended and restated in its entirety as follows:

“The Parties shall use reasonable best efforts to effectuate the transfer of the Sub Shares from Sensus USA and its applicable Subsidiaries to Sensus Lux or one of the other Luxembourg-incorporated Subsidiaries prior to the Closing Date.”

5. Amendment to Exhibit A. Exhibit A to the Agreement is hereby amended and restated in its entirety as set forth on Exhibit A hereto.

6. Effect of the Amendment. Each Party acknowledges that this Amendment constitutes an amendment to the Agreement as contemplated by Section 10.1 of the Agreement. On or after the date hereof, any reference to the Agreement shall constitute a reference to the

 

2


Agreement as amended hereby. Except as expressly modified or amended hereby, all terms and provisions of the Agreement shall continue in full force and effect. Any conflict between the terms herein and in the Agreement shall be governed by the terms of this Amendment.

7. Governing Law. The Parties specifically agree that this Amendment and any dispute hereunder, whether in law or in equity, whether in contract or in tort, by statute or otherwise, shall in all respects be interpreted, read, construed and governed by the internal laws of the State of Delaware, exclusive of its conflicts of law rules.

8. Counterparts. This Amendment may be executed simultaneously in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. The Parties to this Amendment may deliver their executed counterparts by facsimile or other electronic means.

[The remainder of this page is intentionally left blank.]

 

3


IN WITNESS WHEREOF, the Parties have entered into this Amendment as of the date first written above.

 

SELLERS:

 

SENSUS WORLDWIDE LIMITED

 

By:

 

/s/ Dennis Bays

 
 

Name: Dennis Bays

Title: President

 

 

SENSUS INDUSTRIES LIMITED

 
By:  

/s/ Dennis Bays

 
 

Name: Dennis Bays

Title: President

 

 

SENSUS USA INC

 
By:  

/s/ Dennis Bays

 

Name: Dennis Bays

Title: President

 

[Signature page to First Amendment to Share Purchase Agreement]


BUYERS:  

XYLEM INC.

 
By:  

/s/ Patrick Decker

 
 

Name: Patrick Decker

Title: President and Chief Executive Officer

 

 

XYLEM LUXEMBOURG S.À R.L.

 
By:  

/s/ Samir H. Patel

 
 

Name: Samir H. Patel

Title: Manager

 

[Signature page to First Amendment to Share Purchase Agreement]

Exhibit 99.1

 

Xylem Inc.

1 International Drive, Rye Brook N.Y. 10573

Tel +1.914.323.5700 Fax +1.914.696.2960

   LOGO
  

 

Contacts:            Media    Investors
   Kelly McAndrew +1 (914) 323-5969    Phil DeSousa +1 (914) 323-5930
   Kelly.McAndrew@xyleminc.com                    Phil.DeSousa@xyleminc.com

Xylem Inc. reports third quarter 2016 earnings

Company completes Sensus acquisition and also acquires Visenti, a provider of

smart technologies for the management of water networks;

Both additions increase Xylem’s offerings of systems intelligence solutions

 

    Third quarter 2016 earnings per share (EPS) were $0.41, down 15 percent from the prior year period due primarily to increased restructuring, realignment and acquisition-related costs; adjusted EPS1 were $0.54, a 10-percent increase over the previous year

 

    Third quarter 2016 revenue was $897 million; down one percent and flat organically compared with a year ago

 

    Reported operating margin declined 110 basis points to 12.2 percent; adjusted operating margin increased 90 basis points to 14.6 percent, reflecting strong execution on productivity initiatives

 

    Company continues to execute its capital deployment strategy, successfully completing the Sensus acquisition on October 31 and acquiring Singapore-based Visenti, provider of leak detection and pressure management products and services

RYE BROOK, N.Y., November 1, 2016 – Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported third quarter 2016 net income of $73 million, or $0.41 per share, a decrease of 15 percent year-over-year reflecting higher restructuring, realignment and acquisition-related costs. Adjusted net income in the quarter was $97 million or $0.54 per share, a 10-percent increase over the prior year period. Third quarter revenue was $897 million, which was down one percent from third quarter 2015 and flat organically. The robust revenue growth in the public utility end market was offset by weaker conditions in the industrial sector. Reported operating margin in the quarter declined 110 basis points to 12.2 percent. On an adjusted basis, operating margin grew 90 basis points to 14.6 percent as strong execution on productivity initiatives more than offset inflation and targeted investments in strategic growth initiatives.

“I am pleased with our team’s performance this quarter as they executed well in a mixed market environment, while successfully advancing on our capital deployment strategy as well,” said Patrick Decker, Xylem President and Chief Executive Officer. “We continued to capitalize on a strong public utility end market, where we grew 10 percent globally and 25 percent in the U.S. in the quarter. This growth helped offset the softness in the broader industrial sector. We continue to drive cost savings from global procurement and lean and six sigma initiatives. In addition, we are accelerating certain restructuring actions to mitigate the weaker industrial sector and enable us to continue to drive margin expansion. Our productivity and business simplification initiatives will be key contributors as we continue to invest for stronger growth in the marketplace while further expanding operating margins to enhance our long-term earnings growth.”

 

1  See attachment for definitions of non-GAAP measures and non-GAAP reconciliations


“Yesterday, we completed the acquisition of Sensus, which expands our offerings to customers around the globe and reshapes the growth profile of Xylem as we significantly increase our exposure to the fast-growing public utility end market. This addition also enhances our ability to bring systems intelligence solutions to the marketplace in the water and energy industries. We are well into executing the integration planning of this business, operating as one business today and focused on realizing cost synergies and driving the substantial revenue synergies we expect from this combination.”

Mr. Decker continued, “In addition, we have completed the acquisition of Visenti, which provides products and services for utilities to optimize their drinking water networks, including in the rapidly growing areas of leak detection, pressure management and water quality monitoring. Visenti’s portfolio is highly complementary to the Sensus offerings, and targets utilities’ growing challenge of managing water loss, known as non-revenue water. This addition will enable us to immediately offer more valuable solutions to our customers. We look forward to integrating their capabilities into Xylem and helping them to scale and grow this business.”

Full-year 2016 Outlook

Xylem increased its forecast of full-year 2016 revenue to approximately $3.8 billion, including approximately five-percent growth from completed acquisitions and the unfavorable impacts of foreign exchange. On an organic basis, Xylem’s revenue growth now is anticipated to be one-and-one-half percent.

Xylem is maintaining the same adjusted EPS mid-point for the full year, while narrowing the range of its earnings outlook. Xylem now expects to generate full-year 2016 adjusted operating income of $509 million to $513 million, or adjusted EPS of $2.02 to $2.04. The Company is also updating its projected restructuring and realignment costs to approximately $45 million for the year. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as integration and acquisition-related costs, special charges and discrete tax impacts.

Third Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its businesses serving clean water delivery, wastewater transport and treatment, dewatering and analytical instrumentation.

 

    Third quarter 2016 Water Infrastructure revenue was $554 million, up one percent over the prior year period on a reported basis. This growth reflects continued strength in the public utility end market, which was up 10 percent on a global basis in the quarter and 25 percent in the U.S. In addition, the delivery of a major project in India contributed to the gains. This growth was largely offset by weaker conditions in the industrial end market, notably the ongoing declines in oil and gas in North America and a slowdown in Middle East projects.

 

    Reported segment operating income was $79 million in the third quarter, down from $83 million in the prior year. Adjusted segment operating income was $88 million, a four-percent increase over the $85 million generated in the comparable period a year ago. Operating margin for the quarter decreased 80 basis points to 14.3 percent, reflecting a year-over-year increase in restructuring and realignment charges. Excluding these charges, adjusted operating margin for the segment increased 50 basis points reflecting strong productivity and volume growth, net of inflation, investments in strategic growth initiatives and unfavorable mix.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, and industrial and agricultural applications.


    Third quarter 2016 revenue was $343 million, down two percent from the prior year period on a reported basis and one percent in constant currency. New product sales and channel investments helped drive growth in Europe, which was more than offset by declines in the U.S. industrial and commercial building sectors.    

 

    Segment operating income was $50 million in the third quarter, up from $46 million in third quarter 2015. Adjusted segment operating income grew year over year by $5 million to $53 million, reflecting the impact of accelerated productivity initiatives and cost control measures. Segment operating margin increased 150 basis points to 14.6 percent. On an adjusted basis, segment operating margin grew 180 basis points to 15.5 percent. A strong focus on cost reductions drove this margin expansion, which was partially offset by inflation and ongoing investment in growth initiatives.

Supplemental information on Xylem’s third quarter earnings and reconciliations for non-GAAP items are posted at http://investors.xyleminc.com.

About Xylem

Xylem (XYL) is a leading global water technology company committed to developing innovative technology solutions to the world’s water challenges. The Company’s products and services move, treat, analyze, monitor and return water to the environment in public utility, industrial, residential and commercial building services, and agricultural settings. With its October 2016 acquisition of Sensus, Xylem added smart metering, network technologies and advanced data analytics for water, gas and electric utilities to its portfolio of solutions. The combined Company’s nearly 16,000 employees bring broad applications expertise with a strong focus on identifying comprehensive, sustainable solutions. Headquartered in Rye Brook, New York with 2015 revenue of $3.7 billion, Xylem does business in more than 150 countries through a number of market-leading product brands.

The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at www.xylem.com.

Forward-Looking Statements

This press release contains information that may constitute “forward-looking statements.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking.

These forward-looking statements include statements about the capitalization of Xylem Inc. (the “Company”), the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals. All statements that address operating or financial performance, events or developments that we expect or anticipate will occur in the future – including statements relating to orders, revenues, operating margins and earnings per share growth, and statements expressing general views about future operating results – are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such forward-looking statements. Factors that could cause results to differ materially from those anticipated include: economic, political and other risks associated with our international operations, including military actions, economic sanctions or trade embargoes that could affect customer markets, and non-compliance with laws, including foreign


corrupt practice laws, export and import laws and competition laws; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates; competition and pricing pressures in the markets we serve; the strength of housing and related markets; ability to retain and attract key members of management; our relationship with and the performance of our channel partners; our ability to successfully identify, complete and integrate acquisitions, including the integration of Sensus; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; changes in the value of goodwill or intangible assets; risks relating to product defects, product liability and recalls; governmental investigations; security breaches or other disruptions of our information technology systems; litigation and contingent liabilities; and other factors set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2015, and those described from time to time in subsequent reports filed with the Securities and Exchange Commission. Forward-looking statements made herein are based on information currently available to the Company. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

- ### -


XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

 

     Three Months      Nine Months  

For the periods ended September 30,

   2016      2015      2016      2015  

Revenue

   $ 897       $ 902       $ 2,676       $ 2,659   

Cost of revenue

     540         551         1,621         1,645   
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross profit

     357         351         1,055         1,014   

Selling, general and administrative expenses

     219         207         665         631   

Research and development expenses

     23         23         75         71   

Restructuring charges

     6         1         18         5   
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income

     109         120         297         307   

Interest expense

     16         13         50         41   

Other non-operating income, net

     2         —           3         —     

Gain from sale of businesses

     —           —           —           9   
  

 

 

    

 

 

    

 

 

    

 

 

 

Income before taxes

     95         107         250         275   

Income tax expense

     22         19         40         49   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 73       $ 88       $ 210       $ 226   
  

 

 

    

 

 

    

 

 

    

 

 

 

Earnings per share:

           

Basic

   $ 0.41       $ 0.48       $ 1.17       $ 1.25   

Diluted

   $ 0.41       $ 0.48       $ 1.17       $ 1.24   

Weighted average number of shares:

           

Basic

     179.3         180.8         179.0         181.5   

Diluted

     180.3         181.6         179.8         182.3   

Dividends declared per share

   $ 0.1549       $ 0.1408       $ 0.4647       $ 0.4224   


XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except per share amounts)

 

     September 30,
2016
    December 31,
2015
 

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 659      $ 680   

Receivables, less allowances for discounts and doubtful accounts of $29 and $33 in 2016 and 2015, respectively

     792        749   

Inventories

     488        433   

Prepaid and other current assets

     153        143   
  

 

 

   

 

 

 

Total current assets

     2,092        2,005   

Property, plant and equipment, net

     440        439   

Goodwill

     1,621        1,584   

Other intangible assets, net

     444        435   

Other non-current assets

     181        194   
  

 

 

   

 

 

 

Total assets

   $ 4,778      $ 4,657   
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable

   $ 341      $ 338   

Accrued and other current liabilities

     438        407   

Short-term borrowings and current maturities of long-term debt

     62        78   
  

 

 

   

 

 

 

Total current liabilities

     841        823   

Long-term debt

     1,148        1,196   

Accrued postretirement benefits

     335        335   

Deferred income tax liabilities

     114        118   

Other non-current accrued liabilities

     113        101   
  

 

 

   

 

 

 

Total liabilities

     2,551        2,573   
  

 

 

   

 

 

 
    

Stockholders’ equity:

    

Common Stock – par value $0.01 per share:

    

Authorized 750.0 shares, issued 191.3 shares and 190.2 shares in 2016 and 2015, respectively

     2        2   

Capital in excess of par value

     1,871        1,834   

Retained earnings

     1,011        885   

Treasury stock – at cost 11.9 shares and 11.8 shares in 2016 and 2015, respectively

     (402     (399

Accumulated other comprehensive loss

     (255     (238
  

 

 

   

 

 

 

Total stockholders’ equity

     2,227        2,084   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 4,778      $ 4,657   
  

 

 

   

 

 

 


XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

 

For the nine months ended September 30,

   2016     2015  

Operating Activities

    

Net income

   $ 210      $ 226   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation

     61        69   

Amortization

     36        33   

Share-based compensation

     15        11   

Restructuring charges

     18        5   

Gain from sale of businesses

     —          (9

Other, net

     8        10   

Payments for restructuring

     (11     (11

Changes in assets and liabilities (net of acquisitions):

    

Changes in receivables

     (27     (32

Changes in inventories

     (42     (15

Changes in accounts payable

     14        6   

Other, net

     (8     (33
  

 

 

   

 

 

 

Net Cash – Operating activities

     274        260   
  

 

 

   

 

 

 

Investing Activities

    

Capital expenditures

     (90     (78

Acquisition of business, net of cash acquired

     (70     —     

Proceeds from sale of businesses

     —          1   

Proceeds from the sale of property, plant and equipment

     —          1   

Other, net

     5        2   
  

 

 

   

 

 

 

Net Cash – Investing activities

     (155     (74
  

 

 

   

 

 

 

Financing Activities

    

Short-term debt issued

     62        —     

Short-term debt repaid

     (80     (3

Long-term debt issued

     540        —     

Long-term debt repaid

     (608     —     

Repurchase of common stock

     (3     (128

Proceeds from exercise of employee stock options

     22        14   

Dividends paid

     (84     (77

Other, net

     1        —     
  

 

 

   

 

 

 

Net Cash – Financing activities

     (150     (194
  

 

 

   

 

 

 

Effect of exchange rate changes on cash

     10        (44
  

 

 

   

 

 

 

Net change in cash and cash equivalents

     (21     (52

Cash and cash equivalents at beginning of year

     680        663   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 659      $ 611   
  

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

    

Cash paid during the period for:

    

Interest

   $ 34      $ 37   

Income taxes (net of refunds received)

   $ 60      $ 57   


Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, free cash flow, working capital, and backlog, among others. In addition, we consider certain non-GAAP (or “adjusted”) measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends acquisitions, share repurchases and debt repayment. However, other than with respect to total revenue, we only provide guidance on a non-GAAP basis and do not provide reconciliations of such forward-looking measures to GAAP due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as, integration and acquisition-related costs, special charges and tax related special items. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

“Organic revenue” and “Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation assumes no change in exchange rates from the prior period.

“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation, amortization expense, and share-based compensation. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude restructuring and realignment costs, gain on sale of business and special charges.

“Adjusted Operating Income”, “Adjusted Segment Operating Income”, and “Adjusted EPS” defined as operating income, segment operating income and earnings per share, adjusted to exclude restructuring and realignment costs, gain on sale of businesses, special charges and tax-related special items, as applicable.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of free cash flows does not consider certain non-discretionary cash payments, such as debt.

“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Special charges” defined as costs incurred by the Company, such as interest expense related to the early extinguishment of debt during Q2 2016, initial acquisition and integration related costs (including financing costs related to the bridge loan entered into in Q3 2016 for the Sensus acquisition), costs incurred for the contractual indemnification of tax obligations to ITT and other special non-operating items.

“Tax-related special items” defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, significant reserves for cash repatriation, excess tax benefits/losses and other discrete tax adjustments.


Xylem Inc. Non-GAAP Reconciliation

Reported vs. Organic & Constant Currency Orders

($ Millions)

 

    (As Reported — GAAP)     (As Adjusted — Organic)     Constant Currency  
          (A)     (B)           (C)     (D)     (E) = B+C+D     (F) = E/A     (G) = (E - C) / A  
    Orders     Orders     Change
2016 v. 2015
    % Change
2016 v. 2015
    Acquisitions /
Divestitures
    FX Contribution     Change
Adj. 2016 v. 2015
    % Change
Adj. 2016 v. 2015
       
    2016     2015                                            

Nine Months Ended September 30

                 

Xylem Inc.

    2,757        2,798        (41     -1     (24     59        (6     0     1

Water Infrastructure

    1,700        1,737        (37     -2     (24     44        (17     -1     0

Applied Water

    1,057        1,061        (4     0     —          15        11        1     1

Quarter Ended September 30

                 

Xylem Inc.

    946        939        7        1     (10     15        12        1     2

Water Infrastructure

    604        590        14        2     (10     9        13        2     4

Applied Water

    342        349        (7     -2     —          6        (1     0     0

Quarter Ended June 30

                 

Xylem Inc.

    923        944        (21     -2     (9     13        (17     -2     -1

Water Infrastructure

    562        585        (23     -4     (9     11        (21     -4     -2

Applied Water

    361        359        2        1     —          2        4        1     1

Quarter Ended March 31

                 

Xylem Inc.

    888        915        (27     -3     (5     31        (1     0     0

Water Infrastructure

    534        562        (28     -5     (5     24        (9     -2     -1

Applied Water

    354        353        1        0     —          7        8        2     2


Xylem Inc. Non-GAAP Reconciliation

Reported vs. Organic & Constant Currency Revenue

($ Millions)

 

 

    (As Reported — GAAP)     (As Adjusted — Organic)     Constant Currency  
          (A)     (B)           (C)     (D)     (E) = B+C+D     (F) = E/A     (G) = (E - C) / A  
    Revenue     Revenue     Change
2016 v. 2015
    % Change
2016 v. 2015
    Acquisitions /
Divestitures
    FX Contribution     Change
Adj. 2016 v. 2015
    % Change
Adj. 2016 v. 2015
       
    2016     2015                                            

Nine Months Ended September 30

                 

Xylem Inc.

    2,676        2,659        17        1     (25     54        46        2     3

Water Infrastructure

    1,634        1,602        32        2     (25     41        48        3     5

Applied Water

    1,042        1,057        (15     -1     —          13        (2     0     0

Quarter Ended September 30

                 

Xylem Inc.

    897        902        (5     -1     (8     14        1        0     1

Water Infrastructure

    554        551        3        1     (8     9        4        1     2

Applied Water

    343        351        (8     -2     —          5        (3     -1     -1

Quarter Ended June 30

                 

Xylem Inc.

    932        920        12        1     (11     13        14        2     3

Water Infrastructure

    566        551        15        3     (11     11        15        3     5

Applied Water

    366        369        (3     -1     —          2        (1     0     0

Quarter Ended March 31

                 

Xylem Inc.

    847        837        10        1     (6     27        31        4     4

Water Infrastructure

    514        500        14        3     (6     21        29        6     7

Applied Water

    333        337        (4     -1     —          6        2        1     1


Xylem Inc. Non-GAAP Reconciliation

Adjusted Operating Income

($ Millions)

 

 

     Q1     Q2     Q3     YTD  
     2016     2015     2016     2015     2016     2015     2016     2015  

Total Revenue

                

• Total Xylem

     847        837        932        920        897        902        2,676        2,659   

• Water Infrastructure

     514        500        566        551        554        551        1,634        1,602   

• Applied Water

     333        337        366        369        343        351        1,042        1,057   

Operating Income

                

• Total Xylem

     79        83        109        104        109        120        297        307   

    • Water Infrastructure

     54        47        70        65        79        83        203        195   

    • Applied Water

     39        46        51        51        50        46        140        143   

• Total Segments

     93        93        121        116        129        129        343        338   

Operating Margin

                

• Total Xylem

     9.3     9.9     11.7     11.3     12.2     13.3     11.1     11.5

    • Water Infrastructure

     10.5     9.4     12.4     11.8     14.3     15.1     12.4     12.2

    • Applied Water

     11.7     13.6     13.9     13.8     14.6     13.1     13.4     13.5

• Total Segments

     11.0     11.1     13.0     12.6     14.4     14.3     12.8     12.7

Special Charges

                

• Total Xylem

     4        1        1        —          10        —          15        1   

    • Water Infrastructure

     4        1        1        —          —          —          5        1   

    • Applied Water

     —          —          —          —          —          —          —          —     

• Total Segments

     4        1        1        —          —          —          5        1   

Restructuring & Realignment Costs

                

• Total Xylem

     9        6        11        6        12        4        32        16   

    • Water Infrastructure

     4        5        8        4        9        2        21        11   

    • Applied Water

     3        1        3        2        3        2        9        5   

• Total Segments

     7        6        11        6        12        4        30        16   

Adjusted Operating Income

                

• Total Xylem

     92        90        121        110        131        124        344        324   

    • Water Infrastructure

     62        53        79        69        88        85        229        207   

    • Applied Water

     42        47        54        53        53        48        149        148   

• Total Segments

     104        100        133        122        141        133        378        355   

Adjusted Operating Margin

                

• Total Xylem

     10.9     10.8     13.0     12.0     14.6     13.7     12.9     12.2

    • Water Infrastructure

     12.1     10.6     14.0     12.5     15.9     15.4     14.0     12.9

    • Applied Water

     12.6     13.9     14.8     14.4     15.5     13.7     14.3     14.0

• Total Segments

     12.3     11.9     14.3     13.3     15.7     14.7     14.1     13.4


Xylem Inc. Non-GAAP Reconciliation

Adjusted Diluted EPS

($ Millions, except per share amounts)

 

     Q3 2016     Q3 2015  
     As Reported     Adjustments            Adjusted     As Reported     Adjustments            Adjusted  

Total Revenue

     897             897        902             902   

Operating Income

     109        22        a         131        120        4        a         124   

Operating Margin

     12.2 %           14.6 %      13.3 %           13.7 % 

Interest Expense

     (16     4        b         (12     (13          (13

Other Non-Operating Income (Expense)

     2             2        —          2        b         2   
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Income before Taxes

     95        26           121        107        6           113   

Provision for Income Taxes

     (22     (2     c         (24     (19     (4     c         (23
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Net Income

     73        24           97        88        2           90   
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Diluted Shares

     180.3             180.3        181.6             181.6   

Diluted EPS

   $ 0.41      $  0.13         $ 0.54      $ 0.48      $  0.01         $ 0.49   
     Q3 YTD 2016     Q3 YTD 2015  
     As Reported     Adjustments            Adjusted     As Reported     Adjustments            Adjusted  

Total Revenue

     2,676             2,676        2,659             2,659   

Operating Income

     297        47        a         344        307        17        a         324   

Operating Margin

     11.1 %           12.9 %      11.5 %           12.2 % 

Interest Expense

     (50     12        b         (38     (41          (41

Other Non-Operating Income (Expense)

     3             3        —          4        b         4   

Gain from sale of businesses

     —               —          9        (9        —     
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Income before Taxes

     250        59           309        275        12           287   

Provision for Income Taxes

     (40     (23     c         (63     (49     (10     c         (59
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Net Income

     210        36           246        226        2           228   
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Diluted Shares

     179.8             179.8        182.3             182.3   

Diluted EPS

   $ 1.17      $ 0.20         $ 1.37      $ 1.24      $ 0.01         $ 1.25   

 

a Restructuring & realignment costs of $12 million and $4 million in the third quarter of 2016 and 2015, respectively, and special charges of $10 million of initial acquisition and integration costs in the third quarter of 2016. Restructuring & realignment costs of $32 million and $16 million year-to-date 2016 and 2015, respectively, and special charges of $15 million of initial acquisition and integration costs and $1 million of other special charges year-to-date 2016 and 2015, respectively.
b Third quarter special charges of $4 million of financing costs related to the bridge loan entered into for the Sensus acquisition in 2016 and $2 million of other special charges in 2015. Year-to-date special charges of $ $4 million of financing costs related to the bridge loan entered into for the Sensus acquisition and $8 million of costs related to the early extinguishment of debt in 2016 and $4 million of other special charges in 2015.
c Net tax impact on restructuring & realignment costs of $4 million and $1 million and on special charges of $2 million and $0 million, and tax-related special items of $4 million of benefit and $3 million of expense for the third quarter of 2016 and 2015, respectively. Net tax impact on restructuring & realignment costs of $9 million and $4 million and on special charges of $7 million and $0 million, and tax-related special charges of $7 million and $6 million for year-to-date 2016 and 2015, respectively.


Xylem Inc. Non-GAAP Reconciliation

Net Cash - Operating Activities vs. Free Cash Flow

($ Millions)

 

     Q1     Q2     Q3     Nine Months Ended  
     2016     2015     2016     2015     2016     2015     2016     2015  

Net Cash - Operating Activities

   $ 41      $ 39      $ 84      $ 84      $ 149      $ 137      $ 274      $ 260   

Capital Expenditures

     (37     (37     (25     (20     (28     (21     (90     (78
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Free Cash Flow

   $ 4      $ 2      $ 59      $ 64      $ 121      $ 116      $ 184      $ 182   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Income

     66        64        71        74        73        88        210        226   

Gain from sale of businesses

     —          9        —          —          —          —          —          9   

Special Charges - Interest

     —          —          (8     —          —          —          (8     —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Income, excluding gain on sale of businesses and Special Charges - Interest

   $ 66      $ 55      $ 79      $ 74      $ 73      $ 88      $ 218      $ 217   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Free Cash Flow Conversion

     6     4     75     86     166     132     84     84